Skip to main content

Beneficial ownership — 13D / 13G

87,240 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Stonepine Capital Management, LLC XERS Xeris Biopharma Holdings, Inc. 13G/A 4.3% 2y
GLAZER CAPITAL, LLC ARCE Arco Platform Limited Class A Common Shares 13G/A 0% 2y
David A. Duffield WDAY Workday, Inc. 13G/A 20.45% 2y
SB INVESTMENT ADVISERS (UK) LTD DASH DoorDash, Inc. 13G/A 2.6% 2y
Bellevue Asset Management (UK) Ltd. CDNA CareDx, Inc. 13G/A 7.3% 2y
JANUS HENDERSON GROUP PLC OSIS Osi Systems Inc 13G/A 7.2% 2y
Chinh E. Chu DNB Dun & Bradstreet Holdings, Inc. 13G/A 2.95% 2y
Polar Asset Management Partners Inc. MSSAF Metal Sky Star Acquisition Corp 13G 7% 2y
GIC Private Ltd VNET VNET Group, Inc. 13G/A 2.17% 2y
David McJannet HCP HashiCorp, Inc. Class A Common Stock 13G 5.4% 2y
Dodge & Cox TECK Teck Resources Ltd 13G/A 3.6% 2y
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC RVLV Revolve Group, Inc. 13G/A 17.32% 2y
GLAZER CAPITAL, LLC DISA Disruptive Acquisition Corporation I Class A Ordinary Shares 13G/A 0% 2y
Leviticus Partners LP LPTH Lightpath Technologies Inc 13G/A 7.78% 2y
Polar Capital Holdings Plc RVNC Revance Therapeutics, Inc. 13G/A 3.6% 2y
VALUEWORKS LLC MSB Mesabi Trust 13G/A 6.1% 2y
SANDS CAPITAL MANAGEMENT, LLC OKTA Okta, Inc. 13G 5.3% 2y
SUVRETTA CAPITAL MANAGEMENT, LLC TERN Terns Pharmaceuticals, Inc. 13G/A 9.5% 2y
HAMILTON LANE ADVISORS LLC UTI Universal Technical Institute Inc 13G/A 4% 2y
Yaskawa Electric Corporation TGAN Transphorm, Inc. Common Stock 13G/A 7.05% 2y
Dryden Capital, LLC PFTA Perception Capital Corp. III Class A Ordinary Share 13G 5.1% 2y
Pathfinder Acquisition LLC MVLA Movella Holdings Inc. Common Stock 13G/A 14.81% 2y
Ariel Gordon. NRSN NeuroSense Therapeutics Ltd. 13G/A 6.9% 2y
NORTHERN TRUST CORP VFC V F Corp 13G/A 6.1% 2y
Karpus Management, Inc. OCAX OCA Acquisition Corp. Class A Common Stock 13G/A 9.29% 2y
ATW SPAC MANAGEMENT LLC OCEA Ocean Biomedical, Inc. 13G/A 0% 2y
JANUS HENDERSON GROUP PLC AKRO Akero Therapeutics, Inc. Common Stock 13G/A 7.7% 2y
William Tai-Wei Ho INAB In8bio, Inc. 13G/A 7.1% 2y
Park National Bank, Trustee By: Amber L Cummins, AVP and Trust Officer PRK Park National Corp 13G/A 9% 2y
Unit Giant Limited SNTG Sentage Holdings Inc. 13G 58.93% 2y
Karpus Management, Inc. NAD Nuveen Quality Municipal Income Fund 13G 5.04% 2y
CANNELL CAPITAL LLC LDI loanDepot, Inc. 13G 5.31% 2y
GENDELL JEFFREY L DXYN Dixie Group Inc 13G/A 9.97% 2y
SUVRETTA CAPITAL MANAGEMENT, LLC KURA Kura Oncology, Inc. 13G/A 9.99% 2y
Serent Capital Partners UGP III, LLC MLNK MeridianLink, Inc. 13G/A 3.53% 2y
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC HLI Houlihan Lokey, Inc. 13G/A 5.38% 2y
SYSTEMATIC FINANCIAL MANAGEMENT LP KVHI Kvh Industries Inc \De\ 13G 8.02% 2y
GATES FOUNDATION TRUST MXF Mexico Fund Inc 13G/A 4.9% 2y
SANDS CAPITAL MANAGEMENT, LLC NET Cloudflare, Inc. 13G/A 3.6% 2y
SYSTEMATIC FINANCIAL MANAGEMENT LP SILC Silicom Ltd. 13G 0.18% 2y
Mizuho Financial Group, Inc. CCTSF Cactus Acquisition Corp. 1 Ltd 13G 5.87% 2y
Dodge & Cox FISV Fiserv Inc 13G/A 5.8% 2y
Dodge & Cox GAP Gap Inc 13G/A 10% 2y
Boston Partners BTMD biote Corp. 13G/A 2.45% 2y
Affinity Asset Advisors, LLC SYRE Spyre Therapeutics, Inc. 13G/A 1.81% 2y
Van Berkom & Associates Inc. CRNC Cerence Inc. 13G/A 9.57% 2y
CANNELL CAPITAL LLC BBW Build-A-Bear Workshop Inc 13G/A 5.83% 2y
Archon Capital Management LLC ARAY Accuray Inc 13G/A 6.71% 2y
Darren Maupin NMM Navios Maritime Partners L.P. 13G 16.3% 2y
Daniel Lau TSAT Telesat Corp 13G/A 5.5% 2y